'Sunshine and Blue Skies' Ahead For Johnson & Johnson (JNJ) Following Strong Q2 Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq hits intraday record high on tech boost, Mideast negotiation hopes
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil prices rise on Trump timeline for Iran peace deal: after US elections
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Johnson & Johnson (JNJ) Tops Q2 EPS by 22c, Updates FY Guidance
July 21, 2021 6:28 AM EDTJohnson & Johnson (NYSE: JNJ) reported Q2 EPS of $2.48, $0.22 better than the analyst estimate of $2.26. Revenue for the quarter came in at $23.31 billion versus the consensus estimate of $22.19 billion.
GUIDANCE:
Johnson & Johnson sees FY2021 EPS of $9.60-$9.70, versus the consensus of $9.52.... More
